Sage Therapeutic Stock Price on December 2, 2024
| SAGE Stock | USD 7.25 0.10 1.36% |
Below is the normalized historical share price chart for Sage Therapeutic extending back to July 18, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Sage Therapeutic stands at 7.25, as last reported on the 1st of February, with the highest price reaching 7.25 and the lowest price hitting 7.25 during the day.
If you're considering investing in Sage Stock, it is important to understand the factors that can impact its price. Sage Therapeutic appears to be relatively risky, given 3 months investment horizon. Sage Therapeutic owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0879, which indicates the firm had a 0.0879 % return per unit of risk over the last 3 months. By inspecting Sage Therapeutic's technical indicators, you can evaluate if the expected return of 0.53% is justified by implied risk. Please review Sage Therapeutic's Semi Deviation of 5.12, risk adjusted performance of 0.0219, and Coefficient Of Variation of 6345.08 to confirm if our risk estimates are consistent with your expectations.
The current year's Other Stockholder Equity is expected to grow to about 4.1 B, whereas Total Stockholder Equity is forecasted to decline to about 802.6 M. . At present, Sage Therapeutic's Price To Book Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Fair Value is expected to grow to 1.53, whereas Price Earnings Ratio is forecasted to decline to (2.26). Sage Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of July 2014 | 200 Day MA 8.7747 | 50 Day MA 5.894 | Beta 0.924 |
Sage |
Sharpe Ratio = 0.0879
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SAGE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.0 actual daily | 53 53% of assets are less volatile |
Expected Return
| 0.53 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average Sage Therapeutic is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sage Therapeutic by adding it to a well-diversified portfolio.
Price Book 0.8148 | Enterprise Value Ebitda (0.33) | Price Sales 4.2258 | Shares Float 48.5 M | Wall Street Target Price 8.6371 |
Related Headline
Terns Pharmaceuticals Headline on 2nd of December 2024
Terns Pharmaceuticals Reports Inducement Grant to New Employ... by finance.yahoo.com
FOSTER CITY, Calif., Dec. 02, 2024 -- Terns Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today announced that it has granted as of December 1, 2024 an equity inducement award to a new employee under the terms of the 2022 Employment Inducement Award Plan, as amended . The equi
Sage Therapeutic Valuation on December 2, 2024
It is possible to determine the worth of Sage Therapeutic on a given historical date. On December 2, 2024 Sage was worth 5.47 at the beginning of the trading date compared to the closed value of 5.79. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Sage Therapeutic stock. Still, in general, we apply an absolute valuation method to find Sage Therapeutic's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sage Therapeutic where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Sage Therapeutic's related companies.
| Open | High | Low | Close | Volume | |
| 5.50 | 5.59 | 5.42 | 5.47 | 329,870 | |
12/02/2024 | 5.47 | 5.83 | 5.45 | 5.79 | 972,431 |
| 5.78 | 5.78 | 5.53 | 5.60 | 672,750 |
| Backtest Sage Therapeutic | | | Sage Therapeutic History | | | Sage Therapeutic Valuation | Previous | Next |
Sage Therapeutic Trading Date Momentum on December 2, 2024
| On December 03 2024 Sage Therapeutic was traded for 5.60 at the closing time. The top price for the day was 5.78 and the lowest listed price was 5.53 . The trading volume for the day was 672.8 K. The trading history from December 3, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 3.28% . The trading price change against the current closing price is 1.04% . |
Sage Therapeutic Fundamentals Correlations and Trends
By evaluating Sage Therapeutic's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Sage Therapeutic's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Sage financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Sage Therapeutic Stock history
Sage Therapeutic investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sage is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sage Therapeutic will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sage Therapeutic stock prices may prove useful in developing a viable investing in Sage Therapeutic
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 68.8 M | 45.7 M | |
| Net Loss | -479.5 M | -455.5 M |
Sage Therapeutic Quarterly Net Working Capital |
|
Sage Therapeutic Stock Technical Analysis
Sage Therapeutic technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Sage Therapeutic Period Price Range
Low | February 1, 2025
| High |
0.00 | 0.00 |
Sage Therapeutic cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Sage Therapeutic February 1, 2025 Market Strength
Market strength indicators help investors to evaluate how Sage Therapeutic stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sage Therapeutic shares will generate the highest return on investment. By undertsting and applying Sage Therapeutic stock market strength indicators, traders can identify Sage Therapeutic entry and exit signals to maximize returns
Sage Therapeutic Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Sage Therapeutic's price direction in advance. Along with the technical and fundamental analysis of Sage Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sage to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0219 | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.61) | |||
| Sortino Ratio | 7.0E-4 | |||
| Treynor Ratio | 0.0558 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Sage Stock analysis
When running Sage Therapeutic's price analysis, check to measure Sage Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sage Therapeutic is operating at the current time. Most of Sage Therapeutic's value examination focuses on studying past and present price action to predict the probability of Sage Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sage Therapeutic's price. Additionally, you may evaluate how the addition of Sage Therapeutic to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |